Atlas Trials

Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck)

Clinical trial NCT02479854 · COMPLETED

Trial details

NCT number
NCT02479854
Sponsor
Genuine Research Center, Egypt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-04-01
Primary completion
2014-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.